Report Detail

Request for Sample of this report

Pharma & Healthcare Global BCG Vaccine for Tuberculosis (TB) Market Growth 2022-2028

  • RnM4470089
    • |
  • 22 July, 2022
    • |
  • Global
    • |
  • 115 Pages
    • |
  • LPI(LP Information)
    • |
  • Pharma & Healthcare

As the global economy mends, the 2021 growth of BCG Vaccine for Tuberculosis (TB) will have significant change from previous year. According to our (LP Information) latest study, the global BCG Vaccine for Tuberculosis (TB) market size is USD million in 2022 from USD million in 2021, with a change of % between 2021 and 2022. The global BCG Vaccine for Tuberculosis (TB) market size will reach USD million in 2028, growing at a CAGR of % over the analysis period 2022-2028.

The United States BCG Vaccine for Tuberculosis (TB) market is expected at value of US$ million in 2021 and grow at approximately % CAGR during forecast period 2022-2028. China constitutes a % market for the global BCG Vaccine for Tuberculosis (TB) market, reaching US$ million by the year 2028. As for the Europe BCG Vaccine for Tuberculosis (TB) landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period 2022-2028. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.

Global main BCG Vaccine for Tuberculosis (TB) players cover Merck, Sanofi Pasteur, Japan BCG Lab, and China National Biotec, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.

This report presents a comprehensive overview, market shares, and growth opportunities of BCG Vaccine for Tuberculosis (TB) market by product type, application, key manufacturers and key regions and countries.

Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
Immune Type
Therapy Type

Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Hospitals
Clinics
Others

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
Merck
Sanofi Pasteur
Japan BCG Lab
China National Biotec
AJ Vaccines
Serum Institute of India
Intervax
GSBPL
Statens Serum Institute
Biomed Lublin
ANLIS Malbran
Fundação Ataulpho de Paiva
BB-NCIPD
Taj Pharmaceuticals
Bio Farma
Microgen
Torlakinstitut
Institut Pasteur de Tunis
IVAC


1 Scope of the Report

  • 1.1 Market Introduction
  • 1.2 Years Considered
  • 1.3 Research Objectives
  • 1.4 Market Research Methodology
  • 1.5 Research Process and Data Source
  • 1.6 Economic Indicators
  • 1.7 Currency Considered

2 Executive Summary

  • 2.1 World Market Overview
    • 2.1.1 Global BCG Vaccine for Tuberculosis (TB) Annual Sales 2017-2028
    • 2.1.2 World Current & Future Analysis for BCG Vaccine for Tuberculosis (TB) by Geographic Region, 2017, 2022 & 2028
    • 2.1.3 World Current & Future Analysis for BCG Vaccine for Tuberculosis (TB) by Country/Region, 2017, 2022 & 2028
  • 2.2 BCG Vaccine for Tuberculosis (TB) Segment by Type
    • 2.2.1 Immune Type
    • 2.2.2 Therapy Type
  • 2.3 BCG Vaccine for Tuberculosis (TB) Sales by Type
    • 2.3.1 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Type (2017-2022)
    • 2.3.2 Global BCG Vaccine for Tuberculosis (TB) Revenue and Market Share by Type (2017-2022)
    • 2.3.3 Global BCG Vaccine for Tuberculosis (TB) Sale Price by Type (2017-2022)
  • 2.4 BCG Vaccine for Tuberculosis (TB) Segment by Application
    • 2.4.1 Hospitals
    • 2.4.2 Clinics
    • 2.4.3 Others
  • 2.5 BCG Vaccine for Tuberculosis (TB) Sales by Application
    • 2.5.1 Global BCG Vaccine for Tuberculosis (TB) Sale Market Share by Application (2017-2022)
    • 2.5.2 Global BCG Vaccine for Tuberculosis (TB) Revenue and Market Share by Application (2017-2022)
    • 2.5.3 Global BCG Vaccine for Tuberculosis (TB) Sale Price by Application (2017-2022)

3 Global BCG Vaccine for Tuberculosis (TB) by Company

  • 3.1 Global BCG Vaccine for Tuberculosis (TB) Breakdown Data by Company
    • 3.1.1 Global BCG Vaccine for Tuberculosis (TB) Annual Sales by Company (2020-2022)
    • 3.1.2 Global BCG Vaccine for Tuberculosis (TB) Sales Market Share by Company (2020-2022)
  • 3.2 Global BCG Vaccine for Tuberculosis (TB) Annual Revenue by Company (2020-2022)
    • 3.2.1 Global BCG Vaccine for Tuberculosis (TB) Revenue by Company (2020-2022)
    • 3.2.2 Global BCG Vaccine for Tuberculosis (TB) Revenue Market Share by Company (2020-2022)
  • 3.3 Global BCG Vaccine for Tuberculosis (TB) Sale Price by Company
  • 3.4 Key Manufacturers BCG Vaccine for Tuberculosis (TB) Producing Area Distribution, Sales Area, Product Type
    • 3.4.1 Key Manufacturers BCG Vaccine for Tuberculosis (TB) Product Location Distribution
    • 3.4.2 Players BCG Vaccine for Tuberculosis (TB) Products Offered
  • 3.5 Market Concentration Rate Analysis
    • 3.5.1 Competition Landscape Analysis
    • 3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
  • 3.6 New Products and Potential Entrants
  • 3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for BCG Vaccine for Tuberculosis (TB) by Geographic Region

  • 4.1 World Historic BCG Vaccine for Tuberculosis (TB) Market Size by Geographic Region (2017-2022)
    • 4.1.1 Global BCG Vaccine for Tuberculosis (TB) Annual Sales by Geographic Region (2017-2022)
    • 4.1.2 Global BCG Vaccine for Tuberculosis (TB) Annual Revenue by Geographic Region
  • 4.2 World Historic BCG Vaccine for Tuberculosis (TB) Market Size by Country/Region (2017-2022)
    • 4.2.1 Global BCG Vaccine for Tuberculosis (TB) Annual Sales by Country/Region (2017-2022)
    • 4.2.2 Global BCG Vaccine for Tuberculosis (TB) Annual Revenue by Country/Region
  • 4.3 Americas BCG Vaccine for Tuberculosis (TB) Sales Growth
  • 4.4 APAC BCG Vaccine for Tuberculosis (TB) Sales Growth
  • 4.5 Europe BCG Vaccine for Tuberculosis (TB) Sales Growth
  • 4.6 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales Growth

5 Americas

  • 5.1 Americas BCG Vaccine for Tuberculosis (TB) Sales by Country
    • 5.1.1 Americas BCG Vaccine for Tuberculosis (TB) Sales by Country (2017-2022)
    • 5.1.2 Americas BCG Vaccine for Tuberculosis (TB) Revenue by Country (2017-2022)
  • 5.2 Americas BCG Vaccine for Tuberculosis (TB) Sales by Type
  • 5.3 Americas BCG Vaccine for Tuberculosis (TB) Sales by Application
  • 5.4 United States
  • 5.5 Canada
  • 5.6 Mexico
  • 5.7 Brazil

6 APAC

  • 6.1 APAC BCG Vaccine for Tuberculosis (TB) Sales by Region
    • 6.1.1 APAC BCG Vaccine for Tuberculosis (TB) Sales by Region (2017-2022)
    • 6.1.2 APAC BCG Vaccine for Tuberculosis (TB) Revenue by Region (2017-2022)
  • 6.2 APAC BCG Vaccine for Tuberculosis (TB) Sales by Type
  • 6.3 APAC BCG Vaccine for Tuberculosis (TB) Sales by Application
  • 6.4 China
  • 6.5 Japan
  • 6.6 South Korea
  • 6.7 Southeast Asia
  • 6.8 India
  • 6.9 Australia
  • 6.10 China Taiwan

7 Europe

  • 7.1 Europe BCG Vaccine for Tuberculosis (TB) by Country
    • 7.1.1 Europe BCG Vaccine for Tuberculosis (TB) Sales by Country (2017-2022)
    • 7.1.2 Europe BCG Vaccine for Tuberculosis (TB) Revenue by Country (2017-2022)
  • 7.2 Europe BCG Vaccine for Tuberculosis (TB) Sales by Type
  • 7.3 Europe BCG Vaccine for Tuberculosis (TB) Sales by Application
  • 7.4 Germany
  • 7.5 France
  • 7.6 UK
  • 7.7 Italy
  • 7.8 Russia

8 Middle East & Africa

  • 8.1 Middle East & Africa BCG Vaccine for Tuberculosis (TB) by Country
    • 8.1.1 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales by Country (2017-2022)
    • 8.1.2 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Revenue by Country (2017-2022)
  • 8.2 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales by Type
  • 8.3 Middle East & Africa BCG Vaccine for Tuberculosis (TB) Sales by Application
  • 8.4 Egypt
  • 8.5 South Africa
  • 8.6 Israel
  • 8.7 Turkey
  • 8.8 GCC Countries

9 Market Drivers, Challenges and Trends

  • 9.1 Market Drivers & Growth Opportunities
  • 9.2 Market Challenges & Risks
  • 9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

  • 10.1 Raw Material and Suppliers
  • 10.2 Manufacturing Cost Structure Analysis of BCG Vaccine for Tuberculosis (TB)
  • 10.3 Manufacturing Process Analysis of BCG Vaccine for Tuberculosis (TB)
  • 10.4 Industry Chain Structure of BCG Vaccine for Tuberculosis (TB)

11 Marketing, Distributors and Customer

  • 11.1 Sales Channel
    • 11.1.1 Direct Channels
    • 11.1.2 Indirect Channels
  • 11.2 BCG Vaccine for Tuberculosis (TB) Distributors
  • 11.3 BCG Vaccine for Tuberculosis (TB) Customer

12 World Forecast Review for BCG Vaccine for Tuberculosis (TB) by Geographic Region

  • 12.1 Global BCG Vaccine for Tuberculosis (TB) Market Size Forecast by Region
    • 12.1.1 Global BCG Vaccine for Tuberculosis (TB) Forecast by Region (2023-2028)
    • 12.1.2 Global BCG Vaccine for Tuberculosis (TB) Annual Revenue Forecast by Region (2023-2028)
  • 12.2 Americas Forecast by Country
  • 12.3 APAC Forecast by Region
  • 12.4 Europe Forecast by Country
  • 12.5 Middle East & Africa Forecast by Country
  • 12.6 Global BCG Vaccine for Tuberculosis (TB) Forecast by Type
  • 12.7 Global BCG Vaccine for Tuberculosis (TB) Forecast by Application

13 Key Players Analysis

  • 13.1 Merck
    • 13.1.1 Merck Company Information
    • 13.1.2 Merck BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.1.3 Merck BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.1.4 Merck Main Business Overview
    • 13.1.5 Merck Latest Developments
  • 13.2 Sanofi Pasteur
    • 13.2.1 Sanofi Pasteur Company Information
    • 13.2.2 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.2.3 Sanofi Pasteur BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.2.4 Sanofi Pasteur Main Business Overview
    • 13.2.5 Sanofi Pasteur Latest Developments
  • 13.3 Japan BCG Lab
    • 13.3.1 Japan BCG Lab Company Information
    • 13.3.2 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.3.3 Japan BCG Lab BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.3.4 Japan BCG Lab Main Business Overview
    • 13.3.5 Japan BCG Lab Latest Developments
  • 13.4 China National Biotec
    • 13.4.1 China National Biotec Company Information
    • 13.4.2 China National Biotec BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.4.3 China National Biotec BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.4.4 China National Biotec Main Business Overview
    • 13.4.5 China National Biotec Latest Developments
  • 13.5 AJ Vaccines
    • 13.5.1 AJ Vaccines Company Information
    • 13.5.2 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.5.3 AJ Vaccines BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.5.4 AJ Vaccines Main Business Overview
    • 13.5.5 AJ Vaccines Latest Developments
  • 13.6 Serum Institute of India
    • 13.6.1 Serum Institute of India Company Information
    • 13.6.2 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.6.3 Serum Institute of India BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.6.4 Serum Institute of India Main Business Overview
    • 13.6.5 Serum Institute of India Latest Developments
  • 13.7 Intervax
    • 13.7.1 Intervax Company Information
    • 13.7.2 Intervax BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.7.3 Intervax BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.7.4 Intervax Main Business Overview
    • 13.7.5 Intervax Latest Developments
  • 13.8 GSBPL
    • 13.8.1 GSBPL Company Information
    • 13.8.2 GSBPL BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.8.3 GSBPL BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.8.4 GSBPL Main Business Overview
    • 13.8.5 GSBPL Latest Developments
  • 13.9 Statens Serum Institute
    • 13.9.1 Statens Serum Institute Company Information
    • 13.9.2 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.9.3 Statens Serum Institute BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.9.4 Statens Serum Institute Main Business Overview
    • 13.9.5 Statens Serum Institute Latest Developments
  • 13.10 Biomed Lublin
    • 13.10.1 Biomed Lublin Company Information
    • 13.10.2 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.10.3 Biomed Lublin BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.10.4 Biomed Lublin Main Business Overview
    • 13.10.5 Biomed Lublin Latest Developments
  • 13.11 ANLIS Malbran
    • 13.11.1 ANLIS Malbran Company Information
    • 13.11.2 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.11.3 ANLIS Malbran BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.11.4 ANLIS Malbran Main Business Overview
    • 13.11.5 ANLIS Malbran Latest Developments
  • 13.12 Fundação Ataulpho de Paiva
    • 13.12.1 Fundação Ataulpho de Paiva Company Information
    • 13.12.2 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.12.3 Fundação Ataulpho de Paiva BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.12.4 Fundação Ataulpho de Paiva Main Business Overview
    • 13.12.5 Fundação Ataulpho de Paiva Latest Developments
  • 13.13 BB-NCIPD
    • 13.13.1 BB-NCIPD Company Information
    • 13.13.2 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.13.3 BB-NCIPD BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.13.4 BB-NCIPD Main Business Overview
    • 13.13.5 BB-NCIPD Latest Developments
  • 13.14 Taj Pharmaceuticals
    • 13.14.1 Taj Pharmaceuticals Company Information
    • 13.14.2 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.14.3 Taj Pharmaceuticals BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.14.4 Taj Pharmaceuticals Main Business Overview
    • 13.14.5 Taj Pharmaceuticals Latest Developments
  • 13.15 Bio Farma
    • 13.15.1 Bio Farma Company Information
    • 13.15.2 Bio Farma BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.15.3 Bio Farma BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.15.4 Bio Farma Main Business Overview
    • 13.15.5 Bio Farma Latest Developments
  • 13.16 Microgen
    • 13.16.1 Microgen Company Information
    • 13.16.2 Microgen BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.16.3 Microgen BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.16.4 Microgen Main Business Overview
    • 13.16.5 Microgen Latest Developments
  • 13.17 Torlakinstitut
    • 13.17.1 Torlakinstitut Company Information
    • 13.17.2 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.17.3 Torlakinstitut BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.17.4 Torlakinstitut Main Business Overview
    • 13.17.5 Torlakinstitut Latest Developments
  • 13.18 Institut Pasteur de Tunis
    • 13.18.1 Institut Pasteur de Tunis Company Information
    • 13.18.2 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.18.3 Institut Pasteur de Tunis BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.18.4 Institut Pasteur de Tunis Main Business Overview
    • 13.18.5 Institut Pasteur de Tunis Latest Developments
  • 13.19 IVAC
    • 13.19.1 IVAC Company Information
    • 13.19.2 IVAC BCG Vaccine for Tuberculosis (TB) Product Offered
    • 13.19.3 IVAC BCG Vaccine for Tuberculosis (TB) Sales, Revenue, Price and Gross Margin (2020-2022)
    • 13.19.4 IVAC Main Business Overview
    • 13.19.5 IVAC Latest Developments

14 Research Findings and Conclusion

Summary:
Get latest Market Research Reports on BCG Vaccine for Tuberculosis (TB). Industry analysis & Market Report on BCG Vaccine for Tuberculosis (TB) is a syndicated market report, published as Global BCG Vaccine for Tuberculosis (TB) Market Growth 2022-2028. It is complete Research Study and Industry Analysis of BCG Vaccine for Tuberculosis (TB) market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

Last updated on

REPORT YOU MIGHT BE INTERESTED

Purchase this Report

$3,660.00
$7,320.00
2,938.98
5,877.96
3,422.10
6,844.20
567,775.80
1,135,551.60
305,061.00
610,122.00
Credit card Logo
Sample Question Discount Download PDF

Related Reports

Reason to Buy

  • Trusted By Leaders

    Top executives from leading companies purchase research reports from us. 

  • Shop With Confidence

    We assist you with all the pre-sales enquiries related to any report so that you can buy with confidence.

  • Customer Centric

    Need assistance related to your research requirements? We are just a phone call or an email away.

  • Personalized Solutions

    Our experienced research specialists are here to help you locate the right reports for your need.

  • Secure Checkout

    Shop without being worried about safety & security of your transactions.
    •

Request for Sample of this report

Reports and Markets

mcafree

Contact Us

+1-352-353-0818 (US)

info@reportsandmarkets.com

Support

EMAIL US

Newsletter

KEEP UP TO DATE ON ALL THE LATEST REPORTS


maxmind_logo